Atlas Trials

CD19 CAR T Cells in Children and Adults With Relapsed or Refractory CD19 Positive B Cell Malignancies

Clinical trial NCT04943016 · UNKNOWN

Trial details

NCT number
NCT04943016
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory B-Cell Malignancies
Start date
2021-07-01
Primary completion
2024-12-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.